More to that, the analysis with the ONCOMINE and GENT database have shown that BMP5 expression was apparently down-regulated in multiple cancer types, which includes bladder, breast, colorectal, lung, and ovary cancers. This evidence concerns the gene BMP5 and ovarian cancer.